Canada Markets open in 5 hrs 59 mins

Bosch Limited (BOSCHLTD.BO)

BSE - BSE Delayed Price. Currency in INR
Add to watchlist
13,637.60+151.85 (+1.13%)
As of 3:29PM IST. Market open.
Full screen
Previous Close13,485.75
Open13,550.00
Bid13,550.00 x 0
Ask13,669.00 x 0
Day's Range13,450.00 - 13,808.00
52 Week Range7,874.00 - 17,136.60
Volume1,901
Avg. Volume3,692
Market Cap402.222B
Beta (5Y Monthly)0.88
PE Ratio (TTM)162.16
EPS (TTM)84.10
Earnings DateN/A
Forward Dividend & Yield105.00 (0.78%)
Ex-Dividend DateAug. 04, 2020
1y Target Est20,275.00
  • CNW Group

    The Bosch Emissions Class Action Proposed Settlement

    VANCOUVER, BC, July 10, 2020 /CNW/ - A number of emissions class actions were commenced across Canada concerning 2009-2016 Volkswagen, Audi and Porsche vehicles equipped with diesel engines (the "Emissions Claims"). A separate action against Robert Bosch GmbH (the "Bosch Action") has been certified and is now the subject of a proposed settlement. The certification and settlement of the Bosch Action affects the rights of Bosch Settlement Class Members.

  • BioGX and Bosch Healthcare Solutions announce partnership to develop Infectious disease tests for the Vivalytic platform
    CNW Group

    BioGX and Bosch Healthcare Solutions announce partnership to develop Infectious disease tests for the Vivalytic platform

    BIRMINGHAM, Ala. and STUTTGART, Germany , May 26, 2020 /CNW/ -- BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch Vivalytic all-in-one ...

  • Bosch Developing COVID-19-(SARS-CoV-2) Rapid Testing Kit for the Vivalytic Platform
    CNW Group

    Bosch Developing COVID-19-(SARS-CoV-2) Rapid Testing Kit for the Vivalytic Platform

    WAIBLINGEN, Germany, March 26, 2020 /CNW/ -- Bosch Healthcare Solutions is currently working on the development of a COVID-19 rapid testing kit for the Vivalytic platform and will launch this in April 2020. The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient's sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as nine other possible viral respiratory diseases. With the Vivalytic VRI test, physicians can quickly and efficiently distinguish between different infections with very similar symptoms, like influenza, and immediately begin the appropriate treatment.